François Fontaine

François Fontaine is the current director at OncoDNA. Prior to this, they were the head of quality at OncoDNA group from December 2020 to August 2022. OncoDNA is a theranostic and genomic company with renown expertise in precision oncology. The company provides comprehensive testing of cancer biomarkers (DNA, RNA and proteins) on solid and liquid biopsies as well NGS data interpretation services to oncologists, research institutes and biopharmaceutical companies across the globe. The company headquarters are based in Belgium, and its two entities – IntegraGen, a company specializing in the decryption of the human genome and Biosequence – are headquartered in France and Spain, respectively. The group employs approx. 115 employees in 9 countries, works with an international network of 35 distributors and collaborates with one European-based and one US-based subcontracted accredited laboratories.

During their time as head of quality, François Fontaine managed a team of 4 QA professionals on two sites (Paris & Gosselies). François also set up and deployed a Quality Policy for the group and implemented and maintained certifications & accreditations (ISO 27001, 13485, 17025, CLIA CAP). Additionally, they prepared the company for IVDR (2017/746) compliance.

François Fontaine has a Bachelor's degree in Pharmacy from Université de Namur, a Master's degree in Molecular Biology from Université de Namur, and a Master's degree in Computer Science from Université de Namur. François also has a degree in pharmacy from Université catholique de Louvain.